C. Davie

发表

In vivo 1H-magnetic resonance spectroscopy of the spinal cord in humans

G. Barker, D. Miller, D. MacManus, 2000, Neuroradiology.

Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss.

A. Thompson, G. Barker, D. Miller, 1995, Brain : a journal of neurology.

The role of spectroscopy in parkinsonism

C. Davie, C. Davie, 1998, Movement disorders : official journal of the Movement Disorder Society.

Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations

G. Barker, A. Thompson, G. Barker, 2000, Journal of neurology, neurosurgery, and psychiatry.

A review of Parkinson's disease.

C. Davie, 2008, British medical bulletin.

Toward an outcomes-based health care system: a view from the United Kingdom.

James Mountford, C. Davie, J. Mountford, 2010, JAMA.

Executive function in multiple sclerosis. The role of frontal lobe pathology.

J Foong, A J Thompson, L Rozewicz, 1997, Brain : a journal of neurology.

Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy

C. Marsden, G. Barker, D. Miller, 1995, Annals of neurology.

Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions.

G J Barker, G. Barker, D. Miller, 1994, Brain : a journal of neurology.

Stroke and pregnancy

C. Davie, P. O’brien, C. Neurologist, 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

Neurology in the European Journal of Neurology

M. Brainin, A. Albanese, C. Davie, 2010 .

Toward an Outcomes-Based Health Care System

C. Davie, J. Mountford, 2017 .

Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study

Wai Hoong Chang, A. Banerjee, D. Pillay, 2020, BMJ Open.

MRS to differentiate multiple system atrophy from idiopathic Parkinson's disease

C. Davie, G. Wenning, N. Quinn, 1993, The Lancet.

Proton MRS in Huntington's disease

G. Barker, C. Davie, P. Tofts, 1994, The Lancet.

First-line First-line treatment in treatment in Parkinson's Parkinson's disease disease

C. Davie, A. Schapira, 2005 .

1H Magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis

Geoff J. M. Parker, Gareth J. Barker, David H. Miller, 1999, Journal of Neurology.

Lesion heterogeneity in MS: a study of the relationships between appearances on T1-weighted images, T1 relaxation times and metabilite concentrations

G. Barker, G. Parker, D. Miller, 2000 .

Anticoagulation in cerebral venous sinus thrombosis

C. Davie, 2012, European journal of neurology.

Hyper acute stroke unit services.

C. Davie, A. Rudd, Simon Liu, 2011, Clinical medicine.

1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis

G. Barker, A. Thompson, C. Davie, 1997, Journal of neurology, neurosurgery, and psychiatry.

Characterization of a novel TYMP splice site mutation associated with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)

C. Davie, M. Daras, J. Muddle, 2009, Neuromuscular Disorders.

Seventh nerve palsy as a false localising sign.

C. Davie, P. Kennedy, S. Chiba, 1992, Journal of neurology, neurosurgery, and psychiatry.

Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency

A. Banerjee, H. Hemingway, Wai Hoong Chang, 2020, medRxiv.

Proton magnetic resonance spectroscopy of systemic lupus erythematosus involving the central nervous system

G. Barker, M. Ron, C. Davie, 1995, Journal of Neurology.

Proton magnetic resonance spectroscopy in steele‐richardson‐olszewski syndrome

David H. Miller, G. Barker, C. Davie, 1997, Movement disorders : official journal of the Movement Disorder Society.

Paroxysmal dystonic choreoathetosis: Clinical features and investigation of pathophysiology in a large family

C. Marsden, C. Davie, S. Taylor-Robinson, 2000, Movement disorders : official journal of the Movement Disorder Society.

Systemic Thromboembolism in Pregnancy: Cerebrovascular Disease

C. Davie, H. Cohen, D. Arachchillage, 2015 .

An International Standard Set of Patient-Centered Outcome Measures After Stroke

Mary G. George, Eric E. Smith, J. Bernhardt, 2015, Journal of the Neurological Sciences.

Meeting the ambition of measuring the quality of hospitals' stroke care using routinely collected administrative data: a feasibility study.

Alex Bottle, Paul Aylin, C. Davie, 2013, International journal for quality in health care : journal of the International Society for Quality in Health Care.

Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson disease

D. MacManus, C. Davie, A. Lees, 2004, Neurology.

Dying for the weekend: a retrospective cohort study on the association between day of hospital presentation and the quality and safety of stroke care.

C. Davie, A. Bottle, P. Aylin, 2012, Archives of neurology.

Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis

G. Barker, G. Plant, D. MacManus, 1999, Journal of the Neurological Sciences.

Best practices in the real-world data life cycle

L. Celi, J. Halamka, C. Davie, 2022, PLOS digital health.

Serial magnetisation transfer ratios in gadolinium-enhancing lesions in multiple sclerosis

G. Barker, A. Gass, C. Davie, 1997, Journal of Neurology.

Correlates of executive function in multiple sclerosis: the use of magnetic resonance spectroscopy as an index of focal pathology.

J Foong, A J Thompson, L Rozewicz, 1999, The Journal of neuropsychiatry and clinical neurosciences.

Detection of myelin breakdown products by proton magnetic resonance spectroscopy

G. Barker, C. Davie, W. Mcdonald, 1993, The Lancet.

MATTERS ARISING

G. Barker, D. Miller, C. Davie, 1995 .

Impact on Clinical and Cost Outcomes of a Centralized Approach to Acute Stroke Care in London: A Comparative Effectiveness Before and After Model

A. Thompson, C. Davie, L. Schwamm, 2013, PloS one.

First-line Treatment in Parkinson’s Disease

C. Davie, A. Schapira, 2005, Practical Neurology.

Magnetic resonance spectroscopic study of parkinsonism related to boxing.

G. Barker, C. Davie, A. Lees, 1995, Journal of neurology, neurosurgery, and psychiatry.

H-1 magnetic resonance spectroscopy of normal-appearing white matter in primary progressive multiple sclerosis

D. MacManus, G. Parker, D. Miller, 1998 .

Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup?

G J Barker, A J Thompson, G. Barker, 1999, Journal of neurology, neurosurgery, and psychiatry.

Use of magnetic-resonance spectroscopy to investigate disability in multiple-sclerosis

G. Barker, D. Miller, C. Davie, 1994 .

A review of Parkinson's disease.

C. Davie, 2008, British medical bulletin.

Resolution of left hemisphere cognitive dysfunction in multiple sclerosis with magnetic resonance correlates: a case report.

C. Davie, L. Rozewicz, A. Thompson, 1996, Cognitive neuropsychiatry.